Mizuho Securities Sticks to Their Hold Rating for Apellis Pharmaceuticals (APLS)
In a report released today, Graig Suvannavejh from Mizuho Securities maintained a Hold rating on Apellis Pharmaceuticals (APLS – Research ...
Mizuho Securities Sticks to Its Hold Rating for Five Below (FIVE)
Mizuho Securities analyst David Bellinger maintained a Hold rating on Five Below (FIVE – Research Report) on February 11. The company’s shares ...
Mizuho cuts Alphabet stock price target to $230 from $235
Securities adjusted its outlook on Alphabet Inc. (NASDAQ:GOOGL), reducing the tech giant's price target from $235 to $230, ...
Mizuho cuts Albemarle stock price target to $90 from $105
Securities adjusted its outlook on Albemarle Corporation (NYSE:ALB), a leading producer of lithium, by reducing its price target from $105.00 to $90.00, while keeping a Neutral rating on the stock.
Nasdaq5d
Fund Update: MIZUHO SECURITIES USA LLC opened a $11.0M position in $ANSC stock
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. Note that there may be inaccuracies in these estimates due to filing errors by the funds ...
Nasdaq5d
Fund Update: MIZUHO SECURITIES USA LLC opened a $7.3M position in $GLAC stock
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. Note that there may be inaccuracies in these estimates due to filing errors by the funds ...
Morningstar23d
Mizuho Has More of a Focus on Large Corporate Borrowers Than Some Other Japanese Banks
Mizuho lacks the large consumer finance, credit card, and leasing operations of its two rivals, leaving it dependent on banking, securities, and asset management for future returns. Its wholesale ...